欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0632/001
药品名称Cardioplexol
活性成分
    • MAGNESIUMSULFAT 4.0 mg/ml
    • potassium chloride 0.75 mg/ml
    • prilocaine hydrochloride 3.0 mg/ml
    • XYLITOL 4.5 mg/ml
剂型Solution for cardioplegia
上市许可持有人MIT Gesundheit GmbH Thaerstraße 4a 47533 Kleve, Germany
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Germany (DE)
      Cardioplexol Kardioplege Lösung
    • Belgium (BE)
    • Luxembourg (LU)
    • Spain (ES)
      Cardioplexol solución para cardioplegía
    • Sweden (SE)
    • Finland (FI)
    • Czechia (CZ)
      Cardioplexol roztok pro kardioplegii
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2024/04/04
最近更新日期2024/05/20
药物ATC编码
    • B05XA16 cardioplegia solutions
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase